SpaceX has not set a specific IPO date, but shares will probably start trading in late June or early July. The rocket and satellite manufacturer is reportedly seeking a $1.75 trillion valuation for ...

SpaceX’s plan to go public will reportedly give CEO Elon Musk “virtually unchecked executive authority” and limit the rights of shareholders to sue the company. The plan, reported by Reuters today, ...

However, private secondary marketplaces have low liquidity, high fees, and long settlement times. You also need a high net worth to qualify as an accredited investor. The private fund ETFs also charge ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC’s Jim Cramer said he is growing concerned about speculative excess in the IPO market. He warned that the upcoming SpaceX debut could fuel bubble-like behavior.

Inspire Brands, the owner of fast-food chains Dunkin’, Arby’s and Jimmy John’s, said Friday it had confidentially filed for a US initial public offering, as the consumer IPO market picks up steam ...

Investors can’t seem to get enough of artificial intelligence infrastructure stocks, and that is pointing to massive demand for semiconductor chip designer Cerebras’ upcoming IPO. Cerebras CBRS, which ...

Cerebras prices IPO at $185 a share amid strong demand; Traders got a big first-day pop Michael Nagle / Bloomberg via Getty Images AI chipmaker Cerebras raised more than $5 billion after pricing its ...

Fervo Energy, the geothermal energy startup, saw its market valuation surpass $10 billion in its public market debut, an increase driven by demand for AI data centers — and the energy that can power ...

Cerebras Systems' stock traded lower on Friday, in its first full day of trading after making its monster IPO debut. The semiconductor firm sold 30 million shares, raising $5.5 billion in total.

I last wrote on SpaceX (SPACE) on Mar. 16, 2026. The article rated the stock as a buy after a comparison of its business model against the established United Launch Alliance (ULA). Since then, there ...

The idea was to remind boards of a basic principle of American capitalism: ordinary investors should expect their dollars to buy the same voting rights the big shots ‌receive. One share, one vote was ...

Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning. The autoimmune- and inflammatory-disease-focused company first ...